Sarah E. Lindsay, Aaron Alokozai, Sara L. Eppler, Jeffrey Yao, A. Morris, R. Kamal
{"title":"医疗保健中的决策和成本:患者视角。","authors":"Sarah E. Lindsay, Aaron Alokozai, Sara L. Eppler, Jeffrey Yao, A. Morris, R. Kamal","doi":"10.3113/jsoa.2023.0023","DOIUrl":null,"url":null,"abstract":"Unsustainable spending and unsatisfactory outcomes have prompted a reanalysis of healthcare policy towards value. Several strategies have been proposed as part of this effort including cost sharing plans to shift costs to patients and gain-sharing models to shift risk to health systems. The patient perspective is rarely elicited in policy formation despite efforts to increase patient-centered care. We conducted a prospective study of 118 patients presenting to hand clinic to assess patient perspective of who should constrain treatment options (patient, physician, insurance company, hospital) and be responsible for costs in scenarios of clinical equipoise. We found that patients believed that insurance companies and hospitals should not constrain which treatment options are available to a patient and that physicians and patients should together influence the availability of treatment options. Patients were willing to cost share with insurance companies when choosing more expensive treatments or in the setting of non-life-threatening diseases. In addressing rising healthcare costs, patient perspectives can inform policies designed to increase value. Asking patients to cost share when choosing a more expensive treatment option in the setting of clinical equipoise could be a strategy for health systems to increase value. Level of Evidence: III (Journal of Surgical Orthopaedic Advances 32(1):023-027, 2023).","PeriodicalId":17143,"journal":{"name":"Journal of surgical orthopaedic advances","volume":"275 1","pages":"23-27"},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Decision Making and Cost in Healthcare: The Patient Perspective.\",\"authors\":\"Sarah E. Lindsay, Aaron Alokozai, Sara L. Eppler, Jeffrey Yao, A. Morris, R. Kamal\",\"doi\":\"10.3113/jsoa.2023.0023\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Unsustainable spending and unsatisfactory outcomes have prompted a reanalysis of healthcare policy towards value. Several strategies have been proposed as part of this effort including cost sharing plans to shift costs to patients and gain-sharing models to shift risk to health systems. The patient perspective is rarely elicited in policy formation despite efforts to increase patient-centered care. We conducted a prospective study of 118 patients presenting to hand clinic to assess patient perspective of who should constrain treatment options (patient, physician, insurance company, hospital) and be responsible for costs in scenarios of clinical equipoise. We found that patients believed that insurance companies and hospitals should not constrain which treatment options are available to a patient and that physicians and patients should together influence the availability of treatment options. Patients were willing to cost share with insurance companies when choosing more expensive treatments or in the setting of non-life-threatening diseases. In addressing rising healthcare costs, patient perspectives can inform policies designed to increase value. Asking patients to cost share when choosing a more expensive treatment option in the setting of clinical equipoise could be a strategy for health systems to increase value. Level of Evidence: III (Journal of Surgical Orthopaedic Advances 32(1):023-027, 2023).\",\"PeriodicalId\":17143,\"journal\":{\"name\":\"Journal of surgical orthopaedic advances\",\"volume\":\"275 1\",\"pages\":\"23-27\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of surgical orthopaedic advances\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3113/jsoa.2023.0023\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of surgical orthopaedic advances","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3113/jsoa.2023.0023","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
不可持续的支出和令人不满意的结果促使人们重新分析医疗保健政策的价值取向。作为这一努力的一部分,已经提出了若干战略,包括将费用转嫁给患者的费用分担计划和将风险转嫁给卫生系统的收益分担模式。尽管努力增加以患者为中心的护理,但在政策形成中很少引起患者的观点。我们对118名患者进行了前瞻性研究,以评估患者的观点,即谁应该限制治疗方案(患者、医生、保险公司、医院),并在临床平衡的情况下负责成本。我们发现,患者认为保险公司和医院不应该限制患者可获得的治疗方案,医生和患者应该共同影响治疗方案的可获得性。患者在选择更昂贵的治疗方法或不危及生命的疾病时,愿意与保险公司分担费用。在解决不断上升的医疗保健成本时,患者的观点可以为旨在增加价值的政策提供信息。在临床平衡的背景下,要求患者在选择更昂贵的治疗方案时分担费用,可能是卫生系统增加价值的一种策略。证据等级:III (Journal of Surgical Orthopaedic Advances 32(1):023- 027,2023)。
Decision Making and Cost in Healthcare: The Patient Perspective.
Unsustainable spending and unsatisfactory outcomes have prompted a reanalysis of healthcare policy towards value. Several strategies have been proposed as part of this effort including cost sharing plans to shift costs to patients and gain-sharing models to shift risk to health systems. The patient perspective is rarely elicited in policy formation despite efforts to increase patient-centered care. We conducted a prospective study of 118 patients presenting to hand clinic to assess patient perspective of who should constrain treatment options (patient, physician, insurance company, hospital) and be responsible for costs in scenarios of clinical equipoise. We found that patients believed that insurance companies and hospitals should not constrain which treatment options are available to a patient and that physicians and patients should together influence the availability of treatment options. Patients were willing to cost share with insurance companies when choosing more expensive treatments or in the setting of non-life-threatening diseases. In addressing rising healthcare costs, patient perspectives can inform policies designed to increase value. Asking patients to cost share when choosing a more expensive treatment option in the setting of clinical equipoise could be a strategy for health systems to increase value. Level of Evidence: III (Journal of Surgical Orthopaedic Advances 32(1):023-027, 2023).